
Rovina Pharma and Intermediate Chemicals Private Limited
About Rovina Pharma and Intermediate Chemicals Private Limited
Data last updated:
Rovina Pharma and Intermediate Chemicals Private Limited was a private limited company based in Dombivli East, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 25 December 2019.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2019PTC335003. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹60,000. It was led by directors including Anil Shrikant Manavi and Shrikant Wasudeo Narkhede.
Its last annual general meeting (AGM) was held on 17 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Flat No. 903 Bldg No.16 Regency Estate Kalyan – Shil Road Dyaneshwar Nagar, Dombivli East, Maharashtra, India – 421201.
Company details
Contact details
Rovina Pharma and Intermediate Chemicals Private Limited's registered office is in Dombivli East, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. 903 Bldg No.16 Regency Estate Kalyan – Shil Road Dyaneshwar Nagar, Dombivli East, Maharashtra, India – 421201
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Rovina Pharma and Intermediate Chemicals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Rovina Pharma and Intermediate Chemicals Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Rovina Pharma and Intermediate Chemicals Private Limited, buy the company report.
Board of directors of Rovina Pharma and Intermediate Chemicals Private Limited
Rovina Pharma and Intermediate Chemicals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Shrikant Manavi | Director | 25 Dec 2019 | 6 Years 10 Months | As last reported |
| Shrikant Wasudeo Narkhede Also directs: Oasis Rasayan Industries Private Limited, Eurocel Chemical Industries Private Limited, Irith Chemtech Private Limited and 1 more | Director | 25 Dec 2019 | 6 Years 10 Months | As last reported |
| Kota Praveen Rao | Director | 25 Dec 2019 | 6 Years 10 Months | As last reported |
Auditor
Rovina Pharma and Intermediate Chemicals Private Limited is audited by SUHAS PENDSE & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUHAS PENDSE & ASSOCIATES | FY 2023 | 150634W |
Shareholding
The shareholding of Rovina Pharma and Intermediate Chemicals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rovina Pharma and Intermediate Chemicals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rovina Pharma and Intermediate Chemicals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rovina Pharma and Intermediate Chemicals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rovina Pharma and Intermediate Chemicals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Rovina Pharma and Intermediate Chemicals Private Limited, buy the company report.
Recent activity
Rovina Pharma and Intermediate Chemicals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Anil Shrikant Manavi was appointed as Director on 25 Dec 2019.
Frequently asked questions
Rovina Pharma and Intermediate Chemicals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Rovina Pharma and Intermediate Chemicals was a private limited company based in Dombivli East, Maharashtra, India. The company worked in industrial chemicals, within the chemicals and materials industry. It was incorporated on 25 December 2019 and is registered under CIN U51909MH2019PTC335003. The company has been struck off by the Registrar of Companies and is no longer operational.
Rovina Pharma and Intermediate Chemicals had 3 directors:
- Anil Shrikant Manavi - Director
- Shrikant Wasudeo Narkhede - Director
- Kota Praveen Rao - Director
The CIN (Corporate Identification Number) of Rovina Pharma and Intermediate Chemicals is U51909MH2019PTC335003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Rovina Pharma and Intermediate Chemicals is at Flat No. 903 Bldg No.16 Regency Estate Kalyan – Shil Road Dyaneshwar Nagar, Dombivli East, Maharashtra, India – 421201.
Rovina Pharma and Intermediate Chemicals was incorporated on 25 December 2019. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Rovina Pharma and Intermediate Chemicals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 17 September 2024. Year-wise statements from FY 2020 are in the company report.
No. Rovina Pharma and Intermediate Chemicals has 1 GST registration on record and it is cancelled or inactive.
Rovina Pharma and Intermediate Chemicals operated in the chemicals and materials industry, in the industrial chemicals segment. It worked in this industry before it was struck off.
Anil Shrikant Manavi was appointed as Director on 25 Dec 2019. Kota Praveen Rao was appointed as Director on 25 Dec 2019. Shrikant Wasudeo Narkhede was appointed as Director on 25 Dec 2019.